Christopher W. Krueger - 20 Dec 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Business Officer
Signature
/s/ Christopher Krueger
Issuer symbol
VTYX
Transactions as of
20 Dec 2023
Net transactions value
-$11,210
Form type
4
Filing time
21 Dec 2023, 20:12:48 UTC
Previous filing
19 Dec 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale $11,210 -5,293 -1.8% $2.12 282,119 20 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2 Represents the weighted average share price of an aggregate total of 5,293 shares sold in the price range of $2.07 to $2.155. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.